Best AI Index Fund to Buy
Over the last two years, companies with a focus on…
Buy
82
GLRE Quote, Financials, Valuation and Earnings
Last price:
$14.55
Seasonality move
:
-0.24%
Day range:
$14.06 - $14.58
52-week range:
$11.95 - $15.82
Dividend yield:
0%
P/E ratio:
11.19x
P/S ratio:
0.76x
P/B ratio:
0.75x
Volume:
89.5K
Avg. volume:
88.1K
1-year change:
9.73%
Market cap:
$499M
Revenue:
$648M
EPS (TTM):
$1.29
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target UpsideNo price target exists because of limited analyst coverage.
-
Price Target DownsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Greenlight Capital Re has 45.43% upside to fair value with a price target of -- per share.
GLRE vs. S&P 500
-
Over the past 5 trading days, Greenlight Capital Re has overperformed the S&P 500 by 4.68% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Greenlight Capital Re does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Greenlight Capital Re has grown year-over-year revenues for 1 quarter straight. In the most recent quarter Greenlight Capital Re reported revenues of $179.6M.
Earnings Growth
-
Greenlight Capital Re has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Greenlight Capital Re reported earnings per share of $0.86.
Enterprise value:
511.3M
EV / Invested capital:
0.70x
Price / LTM sales:
0.76x
EV / EBIT:
9.20x
EV / Revenue:
0.78x
PEG ratio (5yr expected):
1.92x
EV / Free cash flow:
4.92x
Price / Operating cash flow:
4.80x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
2.28%
Net Income Margin (TTM):
6.94%
Return On Equity:
7.04%
Return On Invested Capital:
6.41%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $506.8M | $642.3M | $654.5M | $168M | $179.6M | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | $0.89 | $3.00 | $1.29 | $0.78 | $0.86 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $435.4M | $489.2M | $659.4M | $825.3M | $943M | |
| Total Assets | $1.4B | $1.5B | $1.6B | $1.9B | $2.2B | |
| Current Liabilities | $94.1M | $95.7M | $109.2M | $71.6M | $93.7M | |
| Total Liabilities | $950M | $1B | $1.1B | $1.3B | $1.5B | |
| Total Equity | $472.1M | $468.4M | $510M | $624.5M | $666.8M | |
| Total Debt | $95.3M | $99.7M | $62.4M | $72.5M | $59.8M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$21.4M | $26.7M | $103.9M | $18M | $10.4M | |
| Cash From Investing | -$8.3M | -$60.9M | -$82.7M | -$29.8M | -$16M | |
| Cash From Financing | -$36.9M | $10.9M | -$21.2M | -$938K | -$938K | |
| Free Cash Flow | -$21.4M | $26.7M | $103.9M | $18M | $10.4M | |
GLRE
Sector
Market Cap
$499M
$608.2M
Price % of 52-Week High
91.28%
87%
Dividend Yield
0%
2.03%
Shareholder Yield
--
4.07%
1-Year Price Total Return
9.73%
10.08%
Beta (5-Year)
0.667
0.599
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$13.87
200-day SMA
Buy
Level
$13.75
Bollinger Bands (100)
Buy
Level
13.18 - 13.86
Chaikin Money Flow
Sell
Level
-5.3M
20-day SMA
Buy
Level
$13.59
Relative Strength Index (RSI14)
Buy
Level
71.35
ADX Line
Buy
Level
26.72
Williams %R
Sell
Level
-13.355
50-day SMA
Buy
Level
$13.41
MACD (12, 26)
Buy
Level
0.22
25-day Aroon Oscillator
Buy
Level
92
On Balance Volume
Neutral
Level
12.8M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (1.1878)
Sell
CA Score
(Annual)
Level (-0.9911)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (7)
Sell
Ohlson Score
Level (1.3717)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
Sell
Fundamental Score
Level (5)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Greenlight Capital Re Ltd offers property and casualty reinsurance. Its customers are property and casualty insurers, and Greenlight takes on some of their risk in exchange for insurance premiums. It operates through one operating segment: property and casualty reinsurance. It generates revenue through premiums from reinsurance on property and casualty business assumed and income from investments.
Stock Forecast FAQ
In the current month, GLRE has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The GLRE average analyst price target in the past 3 months is --.
-
Where Will Greenlight Capital Re Stock Be In 1 Year?
According to analysts, the consensus estimate is that Greenlight Capital Re share price will rise to -- per share over the next 12 months.
-
What Do Analysts Say About Greenlight Capital Re?
Analysts are divided on their view about Greenlight Capital Re share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Greenlight Capital Re is a Sell and believe this share price will drop from its current level to --.
-
What Is Greenlight Capital Re's Price Target?
The price target for Greenlight Capital Re over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is GLRE A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Greenlight Capital Re is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of GLRE?
You can purchase shares of Greenlight Capital Re via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Greenlight Capital Re shares.
-
What Is The Greenlight Capital Re Share Price Today?
Greenlight Capital Re was last trading at $14.55 per share. This represents the most recent stock quote for Greenlight Capital Re. Yesterday, Greenlight Capital Re closed at $14.44 per share.
-
How To Buy Greenlight Capital Re Stock Online?
In order to purchase Greenlight Capital Re stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Where Will Salesforce Stock Be in 5 Years?
Salesforce (NYSE: CRM) just turned in a quarter that, on…
2 Ultra Safe Dividend Stocks to Buy Now
Historically, blue-chip dividend stocks have been good choices for periods…
Stock Ideas
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Buy
65
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 46x
Buy
52
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Sell
31
REGN alert for Jun 2
Regeneron Pharmaceuticals [REGN] is up 1.82% over the past day.
Buy
55
RGC alert for Jun 2
Regencell Bioscience Holdings [RGC] is down 13.34% over the past day.
Sell
42
AMBA alert for Jun 2
Ambarella [AMBA] is down 0.91% over the past day.
